Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MET Signaling System, Autism and Gastrointestinal Dysfunction

NCT02442115 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT02442115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MET Signaling System, Autism and Gastrointestinal Dysfunction
Lead sponsor
Children's Hospital Los Angeles
Phase
Observational
Overall status
Completed
Start date
April 29, 2015
Completion date
February 6, 2019
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autistic disorder, constipation, gastrointestinal diseases